Is Macular Degeneration hereditary?

Macular degeneration, specifically Age-Related Macular Degeneration (AMD), is a multifactorial condition where genetics play a significant role, but it is not strictly hereditary in the traditional Mendelian sense. While having a family history increases your risk, the development of macular degeneration is influenced by a complex interplay of genetic variants, environmental factors, and lifestyle choices.

Is macular degeneration considered hereditary?

Macular degeneration is generally considered a complex, multifactorial disease rather than a simple hereditary condition caused by a single gene mutation. Research shows that genetics contribute to approximately 45% to 70% of the risk for developing AMD. Unlike conditions following Mendelian inheritance (like autosomal dominant or recessive patterns), macular degeneration involves multiple genetic loci that interact with external triggers like smoking, diet, and sunlight exposure.

What is the genetic risk for family members?

Because macular degeneration is multifactorial, it does not follow a predictable inheritance pattern like 50% or 25% risk. However, the familial aggregation is significant. If you have a first-degree relative with macular degeneration, your lifetime risk of developing the condition is approximately 3 to 4 times higher than that of the general population. While rare, early-onset forms of macular-like dystrophies (such as Stargardt disease or Vitelliform dystrophy) are often strictly hereditary and follow specific autosomal patterns.

Is genetic testing recommended for macular degeneration?

Genetic testing for common, late-onset macular degeneration is not currently recommended for routine clinical use. While researchers have identified over 50 genetic variants associated with the condition—most notably in the CFH and ARMS2 genes—the results do not currently change clinical management or treatment protocols. Genetic counseling is generally reserved for:

• Families experiencing unusually early onset of vision loss (before age 50).


• Individuals with a strong family history of macular dystrophies that appear distinct from typical age-related macular degeneration.


• Those seeking to understand their broader risk profile in the context of clinical research trials.

Next steps

• Schedule a comprehensive dilated eye exam with a retinal specialist to establish a baseline.


• Discuss your family history in detail with your ophthalmologist to differentiate between typical macular degeneration and inherited retinal dystrophies.


• Prioritize modifiable risk factors, such as smoking cessation and nutritional support, which are proven to influence the progression of macular degeneration.


• Join our community at DiseaseMaps.org to connect with the 9 members currently sharing their lived experiences with macular degeneration.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Macular Degeneration.


• Orphanet: Rare eye diseases and genetic classification.


• OMIM (Online Mendelian Inheritance in Man): Age-related macular degeneration susceptibility.


• American Academy of Ophthalmology (AAO): Genetic testing in retinal diseases.